AFJK: Aimei Health Technology Co Ltd Financial Statements
Balance sheet, income statement, and cash flow statements for Aimei Health Technology Co Ltd (AFJK).
$96.58M Market Cap.
AFJK Market Cap. (MRY)
AFJK Shares Outstanding (MRY)
AFJK Assets (MRY)
Total Assets
$73.81M
Total Liabilities
$1.51M
Total Investments
$73.78M
AFJK Income (MRY)
Revenue
$0
Net Income
$2.55M
Operating Expense
$1.06M
AFJK Cash Flow (MRY)
CF Operations
-$672.29K
CF Investing
-$277.70K
CF Financing
$397.48K
AFJK Balance Sheet (MRY)
Metric | 2024 |
|---|---|
Total Assets | $73,814,933 |
Assets Current | $30,384 |
Assets Non-Current | $73,784,549 |
Goodwill & Intangible Assets | $0 |
Shareholders Equity | -$1,476,610 |
Property Plant & Equipment Net | $0 |
Cash & Equivalents | $28,208 |
Accumulated Other Comprehensive Income | $0 |
Deferred Revenue | $0 |
Total Investments | $73,784,549 |
Investments Current | $0 |
Investments Non-Current | $73,784,549 |
Inventory | $0 |
Trade & Non-Trade Receivables | $0 |
Trade & Non-Trade Payables | $289,780 |
Accumulated Retained Earnings (Deficit) | -$1,476,823 |
Tax Assets | $0 |
Tax Liabilities | $0 |
Total Debt | $227,700 |
Debt Current | $227,700 |
Debt Non-Current | $0 |
Total Liabilities | $1,506,994 |
Liabilities Current | $816,994 |
Liabilities Non-Current | $690,000 |
AFJK Income Statement (MRY)
Metric | 2024 |
|---|---|
Revenues | $0 |
Cost of Revenue | $0 |
Selling General & Administrative Expense | $1,064,786 |
Research & Development Expense | $0 |
Operating Expenses | $1,064,786 |
Interest Expense | $0 |
Income Tax Expense | $0 |
Net Loss Income from Discontinued Operations | $0 |
Consolidated Income | $2,552,215 |
Net Income to Non-Controlling Interests | $0 |
Net Income | $2,552,215 |
Preferred Dividends Income Statement Impact | $0 |
Net Income Common Stock | $2,552,215 |
Weighted Average Shares | $9,026,000 |
Weighted Average Shares Diluted | $9,026,000 |
Earning Before Interest & Taxes (EBIT) | $2,552,215 |
Gross Profit | $0 |
Operating Income | -$1,064,786 |
AFJK Cash Flow Statement (MRY)
Metric | 2024 |
|---|---|
Net Cash Flow from Investing | -$277,700 |
Net Cash Flow from Financing | $397,480 |
Net Cash Flow from Operations | -$672,289 |
Net Cash Flow / Change in Cash & Cash Equivalents | -$552,509 |
Net Cash Flow - Business Acquisitions and Disposals | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | -$277,700 |
Capital Expenditure | $0 |
Issuance (Repayment) of Debt Securities | $397,480 |
Issuance (Purchase) of Equity Shares | $0 |
Payment of Dividends & Other Cash Distributions | $0 |
Effect of Exchange Rate Changes on Cash | $0 |
Share Based Compensation | $0 |
Depreciation Amortization & Accretion | $0 |
AFJK Financial Metrics (MRY)
Metric | 2024 |
|---|---|
Gross Margin | - |
Profit Margin | - |
EBITDA Margin | - |
Return on Average Equity (ROAE) | -323.30% |
Return on Average Assets (ROAA) | 3.50% |
Return on Sales (ROS) | - |
Return on Invested Capital (ROIC) | 3.50% |
Dividend Yield | 0% |
Price to Earnings Ratio (P/E) | 38.21 |
Price to Sales Ratio (P/S) | - |
Price to Book Ratio (P/B) | -65.41 |
Debt to Equity Ratio (D/E) | -1.02 |
Earnings Per Share (EPS) | 0.28 |
Sales Per Share (SPS) | 0 |
Free Cash Flow Per Share (FCFPS) | -0.07 |
Book Value Per Share (BVPS) | -0.16 |
Tangible Assets Book Value Per Share (TABVPS) | 8.18 |
Enterprise Value Over EBIT (EV/EBIT) | 38 |
Enterprise Value Over EBITDA (EV/EBITDA) | 37.8 |
Asset Turnover | 0 |
Current Ratio | 0.04 |
Dividends | $0 |
Free Cash Flow (FCF) | -$672,289 |
Enterprise Value (EV) | $96,474,641 |
Earnings Before Tax (EBT) | $2,552,215 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $2,552,215 |
Invested Capital | $73,197,431 |
Working Capital | -$786,610 |
Tangible Asset Value | $73,814,933 |
Market Capitalization | $96,578,200 |
Average Equity | -$789,531 |
Average Assets | $72,450,194 |
Invested Capital Average | $72,021,996 |
Shares | 9,026,000 |
